retatrutide ly3437943 glp-1 gip glucagon receptor agonist 🧬 R3TA is a next-generation peptide being studied for its unique triple- approach to metabolic health. Unlike traditional therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, Next generation dual GLP-1/GIP, GLP-1/glucagon,
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6











:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)













